Wolbachia in the invasive European paper wasp Polistes dominulus

The European paper wasp Polistes dominulus has been expanding its North American range since its introduction in the 1970s. We screened P. dominulus from Italy and the northeastern U.S. for the presence of the intracellular reproductive symbiont Wolbachia. Infection rates among females varied from 16% to 87% among U.S. sites and from 33% to 71% in Italy. We also found infected haploid and diploid males, indicating that this is not a male-killing Wolbachia infection. Our data show that infected individuals from New York, Massachusetts, and Italy carry the same Wolbachia strain, and that some mtDNA haplotypes include both infected and uninfected individuals. We discuss possible implications of Wolbachia infection in this invasive social hymenopteran. Received 28 October 2005; revised 25 January 2006; accepted 17 February 2006.     

Non-active site changes elicit broad-based cross-resistance of the HIV-1 protease to inhibitors.

Three high level, cross-resistant variants of the HIV-1 protease have been analyzed for their ability to bind four protease inhibitors approved by the Food and Drug Administration (saquinavir, ritonavir, indinavir, and nelfinavir) as AIDS therapeutics. The loss in binding energy (DeltaDeltaG(b)) going from the wild-type enzyme to mutant enzymes ranges from 2.5 to 4.4 kcal/mol, 40-65% of which is attributed to amino acid substitutions away from the active site of the protease and not in direct contact with the inhibitor. The data suggest that non-active site changes are collectively a major contributor toward engendering resistance against the protease inhibitor and cannot be ignored when considering cross-resistance issues of drugs against the HIV-1 protease.